Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013

Importance Thyroid cancer incidence has increased substantially in the United States over the last 4 decades, driven largely by increases in papillary thyroid cancer. It is unclear whether the increasing incidence of papillary thyroid cancer has been related to thyroid cancer mortality trends. Objective To compare trends in thyroid cancer incidence and mortality by tumor characteristics at diagnosis. Design, Setting, and Participants Trends in thyroid cancer incidence and incidence-based mortality rates were evaluated using data from the Surveillance, Epidemiology, and End Results-9 (SEER-9) cancer registry program, and annual percent change in rates was calculated using log-linear regression. Exposure Tumor characteristics. Main Outcomes and Measures Annual percent changes in age-adjusted thyroid cancer incidence and incidence-based mortality rates by histologic type and SEER stage for cases diagnosed during 1974-2013. Results Among 77 276 patients (mean [SD] age at diagnosis, 48 [16] years; 58 213 [75%] women) diagnosed with thyroid cancer from 1974-2013, papillary thyroid cancer was the most common histologic type (64 625 cases), and 2371 deaths from thyroid cancer occurred during 1994-2013. Thyroid cancer incidence increased, on average, 3.6% per year (95% CI, 3.2%-3.9%) during 1974-2013 (from 4.56 per 100 000 person-years in 1974-1977 to 14.42 per 100 000 person-years in 2010-2013), primarily related to increases in papillary thyroid cancer (annual percent change, 4.4% [95% CI, 4.0%-4.7%]). Papillary thyroid cancer incidence increased for all SEER stages at diagnosis (4.6% per year for localized, 4.3% per year for regional, 2.4% per year for distant, 1.8% per year for unknown). During 1994-2013, incidence-based mortality increased 1.1% per year (95% CI, 0.6%-1.6%) (from 0.40 per 100 000 person-years in 1994-1997 to 0.46 per 100 000 person-years in 2010-2013) overall and 2.9% per year (95% CI, 1.1%-4.7%) for SEER distant stage papillary thyroid cancer. Conclusions and Relevance Among patients in the United States diagnosed with thyroid cancer from 1974-2013, the overall incidence of thyroid cancer increased 3% annually, with increases in the incidence rate and thyroid cancer mortality rate for advanced-stage papillary thyroid cancer. These findings are consistent with a true increase in the occurrence of thyroid cancer in the United States.

[1]  A. Berrington de González,et al.  Childhood height and body mass index were associated with risk of adult thyroid cancer in a large cohort study. , 2014, Cancer research.

[2]  M. Xing,et al.  Recent incidences and differential trends of thyroid cancer in the USA. , 2016, Endocrine-related cancer.

[3]  S. Mandel,et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[4]  J. Lubin,et al.  The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations. , 2014, The Journal of clinical endocrinology and metabolism.

[5]  A. Pinchera,et al.  Modifications in the papillary thyroid cancer gene profile over the last 15 years. , 2012, The Journal of clinical endocrinology and metabolism.

[6]  Elizabeth E Ward,et al.  Anthropometric Factors and Thyroid Cancer Risk by Histological Subtype: Pooled Analysis of 22 Prospective Studies. , 2016, Thyroid : official journal of the American Thyroid Association.

[7]  R. Tuttle,et al.  Changing Trends in the Incidence of Thyroid Cancer in the United States. , 2016, JAMA otolaryngology-- head & neck surgery.

[8]  H. Vlajinac,et al.  Risk factors for thyroid cancer. , 1994, Neoplasma.

[9]  Sung-Bae Kim,et al.  Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. , 2015, The New England journal of medicine.

[10]  T. Church,et al.  Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States , 2012, Cancer Causes & Control.

[11]  Q. Duh,et al.  Higher rate of BRAF mutation in papillary thyroid cancer over time , 2011, Cancer.

[12]  Martyn Plummer,et al.  Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. , 2016, The New England journal of medicine.

[13]  W. Wiersinga.  Smoking and thyroid , 2013, Clinical endocrinology.

[14]  Alexandra Wollum,et al.  Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. , 2014, JAMA.

[15]  R. Paschke,et al.  Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial , 2014, The Lancet.

[16]  T. Fears,et al.  Graphical presentation of trends in rates. , 1995, American journal of epidemiology.

[17]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[18]  E. Feuer,et al.  A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breast cancer. , 1994, Journal of clinical epidemiology.

[19]  K. Robinson,et al.  Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States. , 2013, Surgery.

[20]  M. Ranney,et al.  Beyond the bedside: Clinicians as guardians of public health, medicine and science , 2020, The American Journal of Emergency Medicine.

[21]  Cheng Cheng,et al.  Less is More: Comparing the 2015 and 2009 American Thyroid Association Guidelines for Thyroid Nodules and Cancer. , 2016, Thyroid : official journal of the American Thyroid Association.

[22]  F. Frasca,et al.  Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors , 2013, Journal of cancer epidemiology.

[23]  P. Stattin,et al.  Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can) , 2011, Cancer Causes & Control.

[24]  Kaliszewski,et al.  American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer , 2017 .

[25]  J. Kopczyński,et al.  Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF V600E Mutation: A Single-Institution Study. , 2016, Thyroid : official journal of the American Thyroid Association.

[26]  Louise Davies,et al.  Current thyroid cancer trends in the United States. , 2014, JAMA otolaryngology-- head & neck surgery.

[27]  C. la Vecchia,et al.  Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors , 2009, Cancer Causes & Control.

[28]  Louise Davies,et al.  Increasing incidence of thyroid cancer in the United States, 1973-2002. , 2006, JAMA.

[29]  J. Stockman,et al.  Exposure to Low-Dose Ionizing Radiation from Medical Imaging Procedures , 2011 .

[30]  India,et al.  Cancer Incidence in Five Continents Vol. X , 2013 .

[31]  H. Risch,et al.  Changing incidence of thyroid cancer. , 2006, JAMA.

[32]  S. Hall,et al.  Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease , 2007, Canadian Medical Association Journal.

[33]  Harlan M Krumholz,et al.  Exposure to low-dose ionizing radiation from medical imaging procedures. , 2009, The New England journal of medicine.

[34]  S. Devesa,et al.  Rising Thyroid Cancer Incidence in the United States by Demographic and Tumor Characteristics, 1980-2005 , 2009, Cancer Epidemiology Biomarkers & Prevention.